Comunicados
Voltar lista
INNATE PHARMA (ISIN : FR0010331421)
Mercado Mnemo Compartimento
PAR
IPH Euronext
Innate Pharma SA (Euronext Paris: FR0010331421 – IPH) announces its turnover for the third quarter of 2009 and updates on its cash situation  
(06/11/09 18:30 CET)
See attachment(s) / Voir document(s) joint(s) / Zie bijlage / Ver documento(s) em anexo
Fonte : INNATE PHARMA   Fornec. : Les Echos
Documentos em anexo
Appendix (PDF, 40 Kb)
Voltar lista